Vitamin D Therapy Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 7.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Vitamin D Therapy Market Analysis
The Vitamin D therapy market size is expected to grow from USD 1.44 billion in 2023 to USD 2.20 billion by 2028, registering a CAGR of 7.00% during the forecast period (2023-2028).
The COVID-19 pandemic helped the vitamin D therapy market to expand more quickly. Vitamin D deficiency is associated with impaired immune response, which can lead to viral infection. Low vitamin D levels are associated with an increased risk of COVID-19 infection. Hence, vitamin D therapy products played a key role during the pandemic. For instance, as per the study report published by Scientific Reports in November 2022, the most significant reduction in COVID-19 infection was seen in veterans with vitamin D blood levels between 0 and 19 ng/ml after supplementation. Compared to White veterans, Black veterans experienced a more significant related COVID-19 risk decrease with supplementation. Hence, the demand for vitamin D therapy products increased during the pandemic, significantly impacting the market. However, as the COVID-19 cases were reduced, the demand for vitamin D therapeutics is unpredictable over the coming years.
The major factors attributing to the market's growth are the presence of a vast patient pool due to a lack of time with sedentary lifestyles and the rapid growth of the aging population. Also, an increased prevalence of malnutrition cases such as osteoporosis and rickets among all age groups in recent years has escalated awareness programs and healthcare expenditure by government authorities across the globe.
The high burden of vitamin D deficiency also impacts the market's growth. For instance, as per the study report published by Edizioni Minerva Medica in May 2022, in the general population of Canton Ticino, Switzerland, vitamin D deficiency was found to be 35.47%, with a significantly higher prevalence in men than in women. The percentage of vitamin deficiency in individuals aged 17 and older is approximately 35.03%; however, it is higher in children and teens aged 0 to 16 when it reaches a substantially higher 43.95%. This shows the high burden of vitamin D deficiency, which is expected to increase demand for vitamin D therapy products and drive the market over the study period.
Furthermore, new product approvals and launches increase the portfolios of the market products, which can drive the market to grow. For instance, in March 2021, DSM launched ampli-D (calcifediol (also known as calcidiol)), a 3 times faster-acting vitamin D supplement in Australia. Ampli-d is a faster and more effective way for Australian consumers to boost vitamin D levels in the body in days and weeks instead of months to support immune health. Thus, the new product approvals and launches are expected to significantly impact the market over the forecast period.
However, the growing consumption of fortified products in public is expected to hinder the market's growth over the forecast period.
Vitamin D Therapy Market Trends
Oral Route of Administration is Expected to Hold the Major Share in the Market Over the Forecast Period
Oral administration of vitamin D is a common practice in treating vitamin D deficiency. The oral route of administration is expected to account for the largest share over the forecast period. This is owing to the ease of administration, safety, efficiency, reduced chances of toxicity coupled with patient compliance, and preference for the oral route due to availability in various forms like chewing gums and tablets, driving the market. In addition, the increasing awareness of vitamin D deficiency due to the high burden, increasing research activities for vitamin D deficiency conditions like osteoporosis and rickets, and the growing elderly population are expected to drive the market over the forecast period.
For instance, as per the report published by BMC Public Health in October 2021, the prevalence of vitamin D deficiency in Europe, the United States, and the Middle East has been reported to range from 20% to 90%. This shows the widespread disease throughout the world with a significant burden on people. Hence, with a high burden of vitamin D deficiency, the demand for treatment increases, which is expected to boost the market over the study period.
Furthermore, in April 2021, the Oireachtas Health Committee launched a report to address Vitamin D deficiency in Ireland. The Committee received information demonstrating widespread vitamin D deficiency in the community, and the report urges the establishment of public health initiatives to treat this deficiency. These public health interventions are advised to lower the risk of respiratory and other ailments, such as osteoporosis. One of the recommendations is to take oral Vitamin D supplementation of 20-25µg/day for the adult population as a public health measure. Hence, with new recommendations, the market is expected to grow over the forecast period through this segment.
North America is Expected to have Significant Share in the Market Over the Forecast Period
North America is expected to have a significant share in the overall vitamin D therapy market throughout the forecast period. This is mainly owing to the presence of leading players based in the United States, focusing on research activities to develop more patient-compliant products with enhanced efficiency coupled with government support and increasing healthcare expenditure, contributing to its outstanding market revenue share in the vitamin D therapy market growth.
Decreased physical activity (PA), obesity, and low social status are also associated with low vitamin D levels. For instance, the CDC report published in January 2022 stated that 25% of American adults are not physically active enough to maintain their health. Physical inactivity rates at the state and territory level range from 17.7% of individuals in Colorado to 49.4% in Puerto Rico. Hence, decreasing physical activity among the people in the region leads to an increased risk of vitamin D deficiency and is likely to raise the demand for treatment and drive the market to grow.
Furthermore, the new product approvals and launches help the market to grow through the widespread of the products in the region. For instance, in November 2022, in Canada, Genestra Brands released two new extra-strength vitamin D supplements, D-Mulsion 2500 and D3 2500. With just one capsule or drop daily, the new extra-strength formula is for those with an increased risk of vitamin D deficiency. Hence, the new approvals and launches of products create new applications and increase the demand, which is expected to drive the market to grow through this region.
Vitamin D Therapy Industry Overview
The Vitamin D therapy market is competitive and consists of several major players. Some prominent players currently dominating the market in terms of market share are acquiring the products, entering into partnerships with other companies to consolidate their market positions across the globe, and others are distributing products. Some companies currently dominating the market are Pfizer Inc, Abbott Laboratories, GSK plc, Biotics Research Corporation, and Ortho Molecular Products.
Vitamin D Therapy Market Leaders
-
Biotics Research Corporation
-
Abbott Laboratories
-
Pfizer Inc
-
GSK plc
-
Ortho Molecular Products
*Disclaimer: Major Players sorted in no particular order
Vitamin D Therapy Market News
- April 2023: Cooper University Health Care researchers found that Vitamin D supplements may reduce the incidence of Influenza-like illness.
- August 2022: Arbro Pharmaceuticals launched Vkap-D3, a plant-based capsule for treating Vitamin D Deficiency in India. Vkap-D3 contains Vitamin D3 60,000 IU in a unique liquid-filled hard vegetarian capsule shell made of HPMC (having plant-based origin) to help treat Vitamin D deficiency.
Vitamin D Therapy Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions & Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Huge Patient Pool with Sedentary Lifestyle and Rapidly Growing Aging Population
- 4.2.2 Rise in Awareness About Vitamin D Deficiency by the Government and Manufacturers
-
4.3 Market Restraints
- 4.3.1 Growing Consumption of Fortified Products
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Buyers/Consumers
- 4.4.2 Bargaining Power of Suppliers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Route of Administration
- 5.1.1 Oral
- 5.1.2 Parenteral
-
5.2 By Purchasing Patterns
- 5.2.1 Prescription
- 5.2.2 Over-The-Counter
-
5.3 By Application
- 5.3.1 Osteoporosis
- 5.3.2 Muscle Weakness
- 5.3.3 Autoimmune Disorders
- 5.3.4 Other Applications
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Ortho Molecular Products
- 6.1.2 Biotics Research Corporation
- 6.1.3 GSK plc
- 6.1.4 Abbott Laboratories
- 6.1.5 Pfizer Inc.
- 6.1.6 Atrium Innovations
- 6.1.7 Merck & Co Inc.
- 6.1.8 Cadila Healthcare Ltd.
- 6.1.9 Alkem Laboratories Ltd
- 6.1.10 Torrent Pharmaceuticals Ltd.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityVitamin D Therapy Industry Segmentation
As per the report's scope, Vitamin D deficiency can lead to a loss of bone density, contributing to osteoporosis and fractures (broken bones). Among the vitamin D compounds, Vitamin D2 /ergocalciferol and vitamin D3 /cholecalciferol are essential for humans. The Vitamin D Therapy Market is Segmented by Route of Administration (Oral and Parenteral), Purchasing Patterns (Prescription and Over-The-Counter), Application (Osteoporosis, Muscle Weakness, Autoimmune Disorders, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value in USD for the above segments.
| By Route of Administration | Oral | |
| Parenteral | ||
| By Purchasing Patterns | Prescription | |
| Over-The-Counter | ||
| By Application | Osteoporosis | |
| Muscle Weakness | ||
| Autoimmune Disorders | ||
| Other Applications | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Vitamin D Therapy Market Research FAQs
What is the current Vitamin D Therapy Market size?
The Vitamin D Therapy Market is projected to register a CAGR of 7% during the forecast period (2024-2029)
Who are the key players in Vitamin D Therapy Market?
Biotics Research Corporation, Abbott Laboratories, Pfizer Inc, GSK plc and Ortho Molecular Products are the major companies operating in the Vitamin D Therapy Market.
Which is the fastest growing region in Vitamin D Therapy Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Vitamin D Therapy Market?
In 2024, the North America accounts for the largest market share in Vitamin D Therapy Market.
What years does this Vitamin D Therapy Market cover?
The report covers the Vitamin D Therapy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Vitamin D Therapy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Vitamin D Therapy Industry Report
Statistics for the 2023 Vitamin D Therapy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Vitamin D Therapy analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
